nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—CXCL8—uterine cancer	0.338	1	CbGaD
Diclofenac—ABCC1—Progesterone—uterine cancer	0.0431	0.105	CbGbCtD
Diclofenac—UGT2B7—Epirubicin—uterine cancer	0.0348	0.085	CbGbCtD
Diclofenac—ABCC1—Dactinomycin—uterine cancer	0.0342	0.0833	CbGbCtD
Diclofenac—CYP1A1—Progesterone—uterine cancer	0.0266	0.0649	CbGbCtD
Diclofenac—ABCC1—Epirubicin—uterine cancer	0.0247	0.0604	CbGbCtD
Diclofenac—UGT1A1—Etoposide—uterine cancer	0.0235	0.0572	CbGbCtD
Diclofenac—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0232	0.0565	CbGbCtD
Diclofenac—ABCC1—Etoposide—uterine cancer	0.0193	0.047	CbGbCtD
Diclofenac—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0162	0.0394	CbGbCtD
Diclofenac—CYP2C8—Progesterone—uterine cancer	0.0154	0.0375	CbGbCtD
Diclofenac—PTGS2—Etoposide—uterine cancer	0.0141	0.0344	CbGbCtD
Diclofenac—ABCC1—Doxorubicin—uterine cancer	0.0132	0.0321	CbGbCtD
Diclofenac—CYP2C19—Progesterone—uterine cancer	0.0129	0.0314	CbGbCtD
Diclofenac—PTGS1—Etoposide—uterine cancer	0.0119	0.029	CbGbCtD
Diclofenac—CYP1A2—Progesterone—uterine cancer	0.0119	0.029	CbGbCtD
Diclofenac—CYP2C9—Progesterone—uterine cancer	0.0107	0.0261	CbGbCtD
Diclofenac—ABCB1—Progesterone—uterine cancer	0.0104	0.0254	CbGbCtD
Diclofenac—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0094	0.0229	CbGbCtD
Diclofenac—CYP2E1—Etoposide—uterine cancer	0.0092	0.0224	CbGbCtD
Diclofenac—ABCB1—Dactinomycin—uterine cancer	0.00825	0.0201	CbGbCtD
Diclofenac—CYP2C8—Etoposide—uterine cancer	0.00687	0.0168	CbGbCtD
Diclofenac—CYP3A4—Progesterone—uterine cancer	0.00623	0.0152	CbGbCtD
Diclofenac—CYP2B6—Doxorubicin—uterine cancer	0.00619	0.0151	CbGbCtD
Diclofenac—CYP1A2—Etoposide—uterine cancer	0.00532	0.013	CbGbCtD
Diclofenac—ABCB1—Etoposide—uterine cancer	0.00465	0.0113	CbGbCtD
Diclofenac—ABCB1—Doxorubicin—uterine cancer	0.00317	0.00774	CbGbCtD
Diclofenac—CYP3A4—Etoposide—uterine cancer	0.00279	0.0068	CbGbCtD
Diclofenac—CYP3A4—Doxorubicin—uterine cancer	0.0019	0.00464	CbGbCtD
Diclofenac—Mefenamic acid—AKR1C1—uterine cancer	0.0017	0.43	CrCbGaD
Diclofenac—Meclofenamic acid—AKR1C3—uterine cancer	0.00127	0.321	CrCbGaD
Diclofenac—PLA2G2A—myometrium—uterine cancer	0.00117	0.0236	CbGeAlD
Diclofenac—CXCL8—myometrium—uterine cancer	0.00116	0.0233	CbGeAlD
Diclofenac—ASIC1—female reproductive system—uterine cancer	0.00113	0.0228	CbGeAlD
Diclofenac—CXCR1—lymph node—uterine cancer	0.00111	0.0224	CbGeAlD
Diclofenac—ASIC1—female gonad—uterine cancer	0.00103	0.0207	CbGeAlD
Diclofenac—PTGS1—oviduct—uterine cancer	0.00101	0.0202	CbGeAlD
Diclofenac—Mefenamic acid—AKR1C3—uterine cancer	0.000987	0.25	CrCbGaD
Diclofenac—PLA2G2A—epithelium—uterine cancer	0.00092	0.0185	CbGeAlD
Diclofenac—CXCL8—uterine cervix—uterine cancer	0.000903	0.0181	CbGeAlD
Diclofenac—KCNQ3—female reproductive system—uterine cancer	0.000901	0.0181	CbGeAlD
Diclofenac—PLA2G2A—smooth muscle tissue—uterine cancer	0.000886	0.0178	CbGeAlD
Diclofenac—CXCL8—smooth muscle tissue—uterine cancer	0.000877	0.0176	CbGeAlD
Diclofenac—PLA2G2A—decidua—uterine cancer	0.000869	0.0175	CbGeAlD
Diclofenac—CXCL8—decidua—uterine cancer	0.00086	0.0173	CbGeAlD
Diclofenac—PLA2G2A—renal system—uterine cancer	0.000853	0.0172	CbGeAlD
Diclofenac—CYP2C18—uterine cervix—uterine cancer	0.000832	0.0167	CbGeAlD
Diclofenac—KCNQ2—female reproductive system—uterine cancer	0.000829	0.0167	CbGeAlD
Diclofenac—PLA2G2A—endometrium—uterine cancer	0.000825	0.0166	CbGeAlD
Diclofenac—CXCL8—endometrium—uterine cancer	0.000816	0.0164	CbGeAlD
Diclofenac—PLA2G2A—mammalian vulva—uterine cancer	0.000798	0.016	CbGeAlD
Diclofenac—KCNQ2—female gonad—uterine cancer	0.000755	0.0152	CbGeAlD
Diclofenac—CYP2C18—mammalian vulva—uterine cancer	0.000728	0.0146	CbGeAlD
Diclofenac—SLCO1C1—renal system—uterine cancer	0.00072	0.0145	CbGeAlD
Diclofenac—UGT2B7—renal system—uterine cancer	0.000718	0.0144	CbGeAlD
Diclofenac—SLC22A11—renal system—uterine cancer	0.0007	0.0141	CbGeAlD
Diclofenac—PLA2G2A—female reproductive system—uterine cancer	0.000683	0.0137	CbGeAlD
Diclofenac—PTGS1—artery—uterine cancer	0.000666	0.0134	CbGeAlD
Diclofenac—ASIC1—lymph node—uterine cancer	0.000663	0.0133	CbGeAlD
Diclofenac—SCN4A—renal system—uterine cancer	0.000662	0.0133	CbGeAlD
Diclofenac—TTR—renal system—uterine cancer	0.000644	0.0129	CbGeAlD
Diclofenac—PTGS2—artery—uterine cancer	0.000637	0.0128	CbGeAlD
Diclofenac—PLA2G2A—female gonad—uterine cancer	0.000622	0.0125	CbGeAlD
Diclofenac—CXCL8—female gonad—uterine cancer	0.000615	0.0124	CbGeAlD
Diclofenac—CXCL8—vagina—uterine cancer	0.000612	0.0123	CbGeAlD
Diclofenac—UGT1A1—renal system—uterine cancer	0.00061	0.0123	CbGeAlD
Diclofenac—ALOX5—smooth muscle tissue—uterine cancer	0.000606	0.0122	CbGeAlD
Diclofenac—ALOX5—decidua—uterine cancer	0.000594	0.0119	CbGeAlD
Diclofenac—UGT2B7—female reproductive system—uterine cancer	0.000575	0.0116	CbGeAlD
Diclofenac—CYP2C18—vagina—uterine cancer	0.000564	0.0113	CbGeAlD
Diclofenac—SLC22A11—female reproductive system—uterine cancer	0.00056	0.0113	CbGeAlD
Diclofenac—TTR—female reproductive system—uterine cancer	0.000516	0.0104	CbGeAlD
Diclofenac—ALOX5—female reproductive system—uterine cancer	0.000467	0.0094	CbGeAlD
Diclofenac—ABCC1—myometrium—uterine cancer	0.000466	0.00937	CbGeAlD
Diclofenac—ALOX5—female gonad—uterine cancer	0.000425	0.00855	CbGeAlD
Diclofenac—PLA2G2A—lymph node—uterine cancer	0.0004	0.00804	CbGeAlD
Diclofenac—ABCC4—renal system—uterine cancer	0.000398	0.008	CbGeAlD
Diclofenac—CXCL8—lymph node—uterine cancer	0.000396	0.00795	CbGeAlD
Diclofenac—SLC22A8—renal system—uterine cancer	0.000395	0.00794	CbGeAlD
Diclofenac—ABCC1—uterine cervix—uterine cancer	0.000363	0.00729	CbGeAlD
Diclofenac—ABCC4—uterus—uterine cancer	0.000354	0.00713	CbGeAlD
Diclofenac—ABCC1—decidua—uterine cancer	0.000345	0.00695	CbGeAlD
Diclofenac—SLCO1C1—lymph node—uterine cancer	0.000337	0.00679	CbGeAlD
Diclofenac—ABCC1—endometrium—uterine cancer	0.000328	0.00659	CbGeAlD
Diclofenac—ABCC4—female reproductive system—uterine cancer	0.000319	0.00641	CbGeAlD
Diclofenac—ABCC1—mammalian vulva—uterine cancer	0.000317	0.00638	CbGeAlD
Diclofenac—PTGS2—myometrium—uterine cancer	0.000307	0.00618	CbGeAlD
Diclofenac—ABCC1—uterus—uterine cancer	0.000302	0.00608	CbGeAlD
Diclofenac—ABCC4—female gonad—uterine cancer	0.00029	0.00583	CbGeAlD
Diclofenac—CYP2C8—renal system—uterine cancer	0.000289	0.00581	CbGeAlD
Diclofenac—CYP1A1—epithelium—uterine cancer	0.000287	0.00578	CbGeAlD
Diclofenac—CYP1A1—uterine cervix—uterine cancer	0.000285	0.00573	CbGeAlD
Diclofenac—CYP2C8—endometrium—uterine cancer	0.000279	0.00561	CbGeAlD
Diclofenac—ALOX5—lymph node—uterine cancer	0.000273	0.0055	CbGeAlD
Diclofenac—CYP1A2—renal system—uterine cancer	0.00027	0.00543	CbGeAlD
Diclofenac—CYP1A1—renal system—uterine cancer	0.000267	0.00536	CbGeAlD
Diclofenac—CYP2B6—renal system—uterine cancer	0.000259	0.00521	CbGeAlD
Diclofenac—PTGS1—epithelium—uterine cancer	0.000253	0.00508	CbGeAlD
Diclofenac—PTGS1—uterine cervix—uterine cancer	0.00025	0.00503	CbGeAlD
Diclofenac—CYP1A1—mammalian vulva—uterine cancer	0.000249	0.00501	CbGeAlD
Diclofenac—ABCC1—female gonad—uterine cancer	0.000247	0.00497	CbGeAlD
Diclofenac—ABCC1—vagina—uterine cancer	0.000246	0.00494	CbGeAlD
Diclofenac—PTGS1—smooth muscle tissue—uterine cancer	0.000243	0.00489	CbGeAlD
Diclofenac—CYP2E1—renal system—uterine cancer	0.000243	0.00489	CbGeAlD
Diclofenac—PTGS2—epithelium—uterine cancer	0.000241	0.00485	CbGeAlD
Diclofenac—CYP2C19—vagina—uterine cancer	0.00024	0.00482	CbGeAlD
Diclofenac—PTGS2—uterine cervix—uterine cancer	0.000239	0.00481	CbGeAlD
Diclofenac—CYP1A1—uterus—uterine cancer	0.000238	0.00478	CbGeAlD
Diclofenac—PTGS1—renal system—uterine cancer	0.000234	0.00471	CbGeAlD
Diclofenac—PTGS2—smooth muscle tissue—uterine cancer	0.000233	0.00468	CbGeAlD
Diclofenac—CYP2C8—female reproductive system—uterine cancer	0.000231	0.00465	CbGeAlD
Diclofenac—PTGS1—endometrium—uterine cancer	0.000226	0.00455	CbGeAlD
Diclofenac—PTGS2—renal system—uterine cancer	0.000224	0.0045	CbGeAlD
Diclofenac—PTGS1—mammalian vulva—uterine cancer	0.000219	0.0044	CbGeAlD
Diclofenac—PTGS2—endometrium—uterine cancer	0.000216	0.00435	CbGeAlD
Diclofenac—CYP1A1—female reproductive system—uterine cancer	0.000214	0.00429	CbGeAlD
Diclofenac—CYP2C8—vagina—uterine cancer	0.000209	0.00421	CbGeAlD
Diclofenac—PTGS1—uterus—uterine cancer	0.000209	0.0042	CbGeAlD
Diclofenac—CYP2B6—female reproductive system—uterine cancer	0.000207	0.00417	CbGeAlD
Diclofenac—CYP2C9—female reproductive system—uterine cancer	0.000205	0.00413	CbGeAlD
Diclofenac—PTGS2—uterus—uterine cancer	0.000199	0.00401	CbGeAlD
Diclofenac—CYP3A4—renal system—uterine cancer	0.000196	0.00393	CbGeAlD
Diclofenac—CYP2E1—female reproductive system—uterine cancer	0.000195	0.00392	CbGeAlD
Diclofenac—CYP1A1—female gonad—uterine cancer	0.000194	0.00391	CbGeAlD
Diclofenac—CYP1A1—vagina—uterine cancer	0.000193	0.00388	CbGeAlD
Diclofenac—ALB—lymph node—uterine cancer	0.000193	0.00387	CbGeAlD
Diclofenac—ABCB1—myometrium—uterine cancer	0.00019	0.00382	CbGeAlD
Diclofenac—CYP2B6—vagina—uterine cancer	0.000188	0.00377	CbGeAlD
Diclofenac—PTGS1—female reproductive system—uterine cancer	0.000188	0.00377	CbGeAlD
Diclofenac—ABCC4—lymph node—uterine cancer	0.000186	0.00375	CbGeAlD
Diclofenac—PTGS2—female reproductive system—uterine cancer	0.000179	0.00361	CbGeAlD
Diclofenac—PTGS1—female gonad—uterine cancer	0.000171	0.00343	CbGeAlD
Diclofenac—PTGS1—vagina—uterine cancer	0.00017	0.00341	CbGeAlD
Diclofenac—PTGS2—female gonad—uterine cancer	0.000163	0.00328	CbGeAlD
Diclofenac—PTGS2—vagina—uterine cancer	0.000162	0.00326	CbGeAlD
Diclofenac—ABCC1—lymph node—uterine cancer	0.000159	0.0032	CbGeAlD
Diclofenac—CYP3A4—female reproductive system—uterine cancer	0.000157	0.00315	CbGeAlD
Diclofenac—ABCB1—epithelium—uterine cancer	0.000149	0.003	CbGeAlD
Diclofenac—ABCB1—uterine cervix—uterine cancer	0.000148	0.00298	CbGeAlD
Diclofenac—ABCB1—decidua—uterine cancer	0.000141	0.00284	CbGeAlD
Diclofenac—ABCB1—renal system—uterine cancer	0.000138	0.00278	CbGeAlD
Diclofenac—ABCB1—endometrium—uterine cancer	0.000134	0.00269	CbGeAlD
Diclofenac—ABCB1—mammalian vulva—uterine cancer	0.000129	0.0026	CbGeAlD
Diclofenac—CYP1A1—lymph node—uterine cancer	0.000125	0.00251	CbGeAlD
Diclofenac—ABCB1—uterus—uterine cancer	0.000123	0.00248	CbGeAlD
Diclofenac—ABCB1—female reproductive system—uterine cancer	0.000111	0.00223	CbGeAlD
Diclofenac—PTGS1—lymph node—uterine cancer	0.00011	0.00221	CbGeAlD
Diclofenac—PTGS2—lymph node—uterine cancer	0.000105	0.00211	CbGeAlD
Diclofenac—ABCB1—female gonad—uterine cancer	0.000101	0.00203	CbGeAlD
Diclofenac—ABCB1—vagina—uterine cancer	0.0001	0.00202	CbGeAlD
Diclofenac—ABCB1—lymph node—uterine cancer	6.49e-05	0.0013	CbGeAlD
Diclofenac—Pancreatitis—Doxorubicin—uterine cancer	5.83e-05	0.000412	CcSEcCtD
Diclofenac—Weight decreased—Epirubicin—uterine cancer	5.82e-05	0.000411	CcSEcCtD
Diclofenac—Dyspnoea—Etoposide—uterine cancer	5.82e-05	0.000411	CcSEcCtD
Diclofenac—Hyperglycaemia—Epirubicin—uterine cancer	5.8e-05	0.00041	CcSEcCtD
Diclofenac—Somnolence—Etoposide—uterine cancer	5.8e-05	0.00041	CcSEcCtD
Diclofenac—Angina pectoris—Doxorubicin—uterine cancer	5.8e-05	0.00041	CcSEcCtD
Diclofenac—Pneumonia—Epirubicin—uterine cancer	5.77e-05	0.000408	CcSEcCtD
Diclofenac—Infestation—Epirubicin—uterine cancer	5.73e-05	0.000405	CcSEcCtD
Diclofenac—Drowsiness—Epirubicin—uterine cancer	5.73e-05	0.000405	CcSEcCtD
Diclofenac—Infestation NOS—Epirubicin—uterine cancer	5.73e-05	0.000405	CcSEcCtD
Diclofenac—Vomiting—Dactinomycin—uterine cancer	5.73e-05	0.000405	CcSEcCtD
Diclofenac—Bronchitis—Doxorubicin—uterine cancer	5.72e-05	0.000405	CcSEcCtD
Diclofenac—Stevens-Johnson syndrome—Epirubicin—uterine cancer	5.68e-05	0.000402	CcSEcCtD
Diclofenac—Rash—Dactinomycin—uterine cancer	5.68e-05	0.000402	CcSEcCtD
Diclofenac—Decreased appetite—Etoposide—uterine cancer	5.67e-05	0.000401	CcSEcCtD
Diclofenac—Pancytopenia—Doxorubicin—uterine cancer	5.65e-05	0.0004	CcSEcCtD
Diclofenac—Renal failure—Epirubicin—uterine cancer	5.64e-05	0.000399	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Etoposide—uterine cancer	5.63e-05	0.000398	CcSEcCtD
Diclofenac—Fatigue—Etoposide—uterine cancer	5.62e-05	0.000398	CcSEcCtD
Diclofenac—Neuropathy peripheral—Epirubicin—uterine cancer	5.62e-05	0.000397	CcSEcCtD
Diclofenac—Stomatitis—Epirubicin—uterine cancer	5.59e-05	0.000395	CcSEcCtD
Diclofenac—Jaundice—Epirubicin—uterine cancer	5.59e-05	0.000395	CcSEcCtD
Diclofenac—Pain—Etoposide—uterine cancer	5.58e-05	0.000394	CcSEcCtD
Diclofenac—Constipation—Etoposide—uterine cancer	5.58e-05	0.000394	CcSEcCtD
Diclofenac—Conjunctivitis—Epirubicin—uterine cancer	5.57e-05	0.000394	CcSEcCtD
Diclofenac—Urinary tract infection—Epirubicin—uterine cancer	5.57e-05	0.000394	CcSEcCtD
Diclofenac—Dysuria—Doxorubicin—uterine cancer	5.56e-05	0.000393	CcSEcCtD
Diclofenac—Upper respiratory tract infection—Doxorubicin—uterine cancer	5.53e-05	0.000391	CcSEcCtD
Diclofenac—Sweating—Epirubicin—uterine cancer	5.5e-05	0.000389	CcSEcCtD
Diclofenac—Pollakiuria—Doxorubicin—uterine cancer	5.5e-05	0.000389	CcSEcCtD
Diclofenac—Haematuria—Epirubicin—uterine cancer	5.47e-05	0.000387	CcSEcCtD
Diclofenac—Photosensitivity reaction—Doxorubicin—uterine cancer	5.43e-05	0.000384	CcSEcCtD
Diclofenac—Hepatobiliary disease—Epirubicin—uterine cancer	5.42e-05	0.000383	CcSEcCtD
Diclofenac—Weight increased—Doxorubicin—uterine cancer	5.41e-05	0.000383	CcSEcCtD
Diclofenac—Epistaxis—Epirubicin—uterine cancer	5.41e-05	0.000382	CcSEcCtD
Diclofenac—Weight decreased—Doxorubicin—uterine cancer	5.38e-05	0.000381	CcSEcCtD
Diclofenac—Sinusitis—Epirubicin—uterine cancer	5.38e-05	0.00038	CcSEcCtD
Diclofenac—Feeling abnormal—Etoposide—uterine cancer	5.38e-05	0.00038	CcSEcCtD
Diclofenac—Hyperglycaemia—Doxorubicin—uterine cancer	5.37e-05	0.00038	CcSEcCtD
Diclofenac—Nausea—Dactinomycin—uterine cancer	5.35e-05	0.000379	CcSEcCtD
Diclofenac—Agranulocytosis—Epirubicin—uterine cancer	5.35e-05	0.000378	CcSEcCtD
Diclofenac—Pneumonia—Doxorubicin—uterine cancer	5.34e-05	0.000377	CcSEcCtD
Diclofenac—Gastrointestinal pain—Etoposide—uterine cancer	5.33e-05	0.000377	CcSEcCtD
Diclofenac—Infestation NOS—Doxorubicin—uterine cancer	5.3e-05	0.000375	CcSEcCtD
Diclofenac—Infestation—Doxorubicin—uterine cancer	5.3e-05	0.000375	CcSEcCtD
Diclofenac—Drowsiness—Doxorubicin—uterine cancer	5.3e-05	0.000375	CcSEcCtD
Diclofenac—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	5.26e-05	0.000372	CcSEcCtD
Diclofenac—Bradycardia—Epirubicin—uterine cancer	5.24e-05	0.000371	CcSEcCtD
Diclofenac—Renal failure—Doxorubicin—uterine cancer	5.21e-05	0.000369	CcSEcCtD
Diclofenac—Neuropathy peripheral—Doxorubicin—uterine cancer	5.2e-05	0.000368	CcSEcCtD
Diclofenac—Urticaria—Etoposide—uterine cancer	5.18e-05	0.000366	CcSEcCtD
Diclofenac—Haemoglobin—Epirubicin—uterine cancer	5.17e-05	0.000366	CcSEcCtD
Diclofenac—Jaundice—Doxorubicin—uterine cancer	5.17e-05	0.000366	CcSEcCtD
Diclofenac—Stomatitis—Doxorubicin—uterine cancer	5.17e-05	0.000366	CcSEcCtD
Diclofenac—Rhinitis—Epirubicin—uterine cancer	5.16e-05	0.000365	CcSEcCtD
Diclofenac—Abdominal pain—Etoposide—uterine cancer	5.16e-05	0.000365	CcSEcCtD
Diclofenac—Body temperature increased—Etoposide—uterine cancer	5.16e-05	0.000365	CcSEcCtD
Diclofenac—Urinary tract infection—Doxorubicin—uterine cancer	5.16e-05	0.000365	CcSEcCtD
Diclofenac—Conjunctivitis—Doxorubicin—uterine cancer	5.16e-05	0.000365	CcSEcCtD
Diclofenac—Hepatitis—Epirubicin—uterine cancer	5.15e-05	0.000364	CcSEcCtD
Diclofenac—Haemorrhage—Epirubicin—uterine cancer	5.15e-05	0.000364	CcSEcCtD
Diclofenac—Hypoaesthesia—Epirubicin—uterine cancer	5.12e-05	0.000362	CcSEcCtD
Diclofenac—Pharyngitis—Epirubicin—uterine cancer	5.11e-05	0.000361	CcSEcCtD
Diclofenac—Sweating—Doxorubicin—uterine cancer	5.09e-05	0.00036	CcSEcCtD
Diclofenac—Urinary tract disorder—Epirubicin—uterine cancer	5.08e-05	0.000359	CcSEcCtD
Diclofenac—Oedema peripheral—Epirubicin—uterine cancer	5.07e-05	0.000359	CcSEcCtD
Diclofenac—Haematuria—Doxorubicin—uterine cancer	5.06e-05	0.000358	CcSEcCtD
Diclofenac—Urethral disorder—Epirubicin—uterine cancer	5.05e-05	0.000357	CcSEcCtD
Diclofenac—Hepatobiliary disease—Doxorubicin—uterine cancer	5.02e-05	0.000355	CcSEcCtD
Diclofenac—Epistaxis—Doxorubicin—uterine cancer	5e-05	0.000354	CcSEcCtD
Diclofenac—Sinusitis—Doxorubicin—uterine cancer	4.98e-05	0.000352	CcSEcCtD
Diclofenac—Visual impairment—Epirubicin—uterine cancer	4.96e-05	0.000351	CcSEcCtD
Diclofenac—Agranulocytosis—Doxorubicin—uterine cancer	4.95e-05	0.00035	CcSEcCtD
Diclofenac—Erythema multiforme—Epirubicin—uterine cancer	4.87e-05	0.000344	CcSEcCtD
Diclofenac—Bradycardia—Doxorubicin—uterine cancer	4.85e-05	0.000343	CcSEcCtD
Diclofenac—Eye disorder—Epirubicin—uterine cancer	4.81e-05	0.00034	CcSEcCtD
Diclofenac—Hypersensitivity—Etoposide—uterine cancer	4.81e-05	0.00034	CcSEcCtD
Diclofenac—Tinnitus—Epirubicin—uterine cancer	4.8e-05	0.000339	CcSEcCtD
Diclofenac—Haemoglobin—Doxorubicin—uterine cancer	4.79e-05	0.000338	CcSEcCtD
Diclofenac—Cardiac disorder—Epirubicin—uterine cancer	4.78e-05	0.000338	CcSEcCtD
Diclofenac—Flushing—Epirubicin—uterine cancer	4.78e-05	0.000338	CcSEcCtD
Diclofenac—Rhinitis—Doxorubicin—uterine cancer	4.77e-05	0.000338	CcSEcCtD
Diclofenac—Hepatitis—Doxorubicin—uterine cancer	4.76e-05	0.000337	CcSEcCtD
Diclofenac—Haemorrhage—Doxorubicin—uterine cancer	4.76e-05	0.000337	CcSEcCtD
Diclofenac—Hypoaesthesia—Doxorubicin—uterine cancer	4.74e-05	0.000335	CcSEcCtD
Diclofenac—Pharyngitis—Doxorubicin—uterine cancer	4.73e-05	0.000334	CcSEcCtD
Diclofenac—Urinary tract disorder—Doxorubicin—uterine cancer	4.7e-05	0.000333	CcSEcCtD
Diclofenac—Oedema peripheral—Doxorubicin—uterine cancer	4.69e-05	0.000332	CcSEcCtD
Diclofenac—Asthenia—Etoposide—uterine cancer	4.68e-05	0.000331	CcSEcCtD
Diclofenac—Angiopathy—Epirubicin—uterine cancer	4.67e-05	0.00033	CcSEcCtD
Diclofenac—Urethral disorder—Doxorubicin—uterine cancer	4.67e-05	0.00033	CcSEcCtD
Diclofenac—Immune system disorder—Epirubicin—uterine cancer	4.65e-05	0.000329	CcSEcCtD
Diclofenac—Mediastinal disorder—Epirubicin—uterine cancer	4.64e-05	0.000328	CcSEcCtD
Diclofenac—Chills—Epirubicin—uterine cancer	4.62e-05	0.000327	CcSEcCtD
Diclofenac—Pruritus—Etoposide—uterine cancer	4.62e-05	0.000326	CcSEcCtD
Diclofenac—Arrhythmia—Epirubicin—uterine cancer	4.6e-05	0.000325	CcSEcCtD
Diclofenac—Visual impairment—Doxorubicin—uterine cancer	4.59e-05	0.000325	CcSEcCtD
Diclofenac—Alopecia—Epirubicin—uterine cancer	4.55e-05	0.000322	CcSEcCtD
Diclofenac—Mental disorder—Epirubicin—uterine cancer	4.51e-05	0.000319	CcSEcCtD
Diclofenac—Erythema multiforme—Doxorubicin—uterine cancer	4.5e-05	0.000318	CcSEcCtD
Diclofenac—Erythema—Epirubicin—uterine cancer	4.48e-05	0.000317	CcSEcCtD
Diclofenac—Malnutrition—Epirubicin—uterine cancer	4.48e-05	0.000317	CcSEcCtD
Diclofenac—Diarrhoea—Etoposide—uterine cancer	4.46e-05	0.000316	CcSEcCtD
Diclofenac—Eye disorder—Doxorubicin—uterine cancer	4.45e-05	0.000315	CcSEcCtD
Diclofenac—Tinnitus—Doxorubicin—uterine cancer	4.44e-05	0.000314	CcSEcCtD
Diclofenac—Cardiac disorder—Doxorubicin—uterine cancer	4.42e-05	0.000313	CcSEcCtD
Diclofenac—Flushing—Doxorubicin—uterine cancer	4.42e-05	0.000313	CcSEcCtD
Diclofenac—Flatulence—Epirubicin—uterine cancer	4.42e-05	0.000312	CcSEcCtD
Diclofenac—Tension—Epirubicin—uterine cancer	4.4e-05	0.000311	CcSEcCtD
Diclofenac—Dysgeusia—Epirubicin—uterine cancer	4.39e-05	0.00031	CcSEcCtD
Diclofenac—Nervousness—Epirubicin—uterine cancer	4.35e-05	0.000308	CcSEcCtD
Diclofenac—Back pain—Epirubicin—uterine cancer	4.33e-05	0.000306	CcSEcCtD
Diclofenac—Angiopathy—Doxorubicin—uterine cancer	4.32e-05	0.000306	CcSEcCtD
Diclofenac—Dizziness—Etoposide—uterine cancer	4.31e-05	0.000305	CcSEcCtD
Diclofenac—Muscle spasms—Epirubicin—uterine cancer	4.31e-05	0.000305	CcSEcCtD
Diclofenac—Immune system disorder—Doxorubicin—uterine cancer	4.3e-05	0.000304	CcSEcCtD
Diclofenac—Mediastinal disorder—Doxorubicin—uterine cancer	4.29e-05	0.000303	CcSEcCtD
Diclofenac—Chills—Doxorubicin—uterine cancer	4.27e-05	0.000302	CcSEcCtD
Diclofenac—Arrhythmia—Doxorubicin—uterine cancer	4.25e-05	0.000301	CcSEcCtD
Diclofenac—Vision blurred—Epirubicin—uterine cancer	4.22e-05	0.000299	CcSEcCtD
Diclofenac—Alopecia—Doxorubicin—uterine cancer	4.21e-05	0.000298	CcSEcCtD
Diclofenac—Mental disorder—Doxorubicin—uterine cancer	4.17e-05	0.000295	CcSEcCtD
Diclofenac—Ill-defined disorder—Epirubicin—uterine cancer	4.16e-05	0.000294	CcSEcCtD
Diclofenac—Vomiting—Etoposide—uterine cancer	4.15e-05	0.000293	CcSEcCtD
Diclofenac—Erythema—Doxorubicin—uterine cancer	4.15e-05	0.000293	CcSEcCtD
Diclofenac—Malnutrition—Doxorubicin—uterine cancer	4.15e-05	0.000293	CcSEcCtD
Diclofenac—Anaemia—Epirubicin—uterine cancer	4.14e-05	0.000293	CcSEcCtD
Diclofenac—Agitation—Epirubicin—uterine cancer	4.12e-05	0.000291	CcSEcCtD
Diclofenac—Rash—Etoposide—uterine cancer	4.11e-05	0.000291	CcSEcCtD
Diclofenac—Dermatitis—Etoposide—uterine cancer	4.11e-05	0.000291	CcSEcCtD
Diclofenac—Headache—Etoposide—uterine cancer	4.09e-05	0.000289	CcSEcCtD
Diclofenac—Flatulence—Doxorubicin—uterine cancer	4.09e-05	0.000289	CcSEcCtD
Diclofenac—Tension—Doxorubicin—uterine cancer	4.07e-05	0.000288	CcSEcCtD
Diclofenac—Dysgeusia—Doxorubicin—uterine cancer	4.06e-05	0.000287	CcSEcCtD
Diclofenac—Malaise—Epirubicin—uterine cancer	4.04e-05	0.000286	CcSEcCtD
Diclofenac—Nervousness—Doxorubicin—uterine cancer	4.03e-05	0.000285	CcSEcCtD
Diclofenac—Vertigo—Epirubicin—uterine cancer	4.03e-05	0.000285	CcSEcCtD
Diclofenac—Syncope—Epirubicin—uterine cancer	4.02e-05	0.000284	CcSEcCtD
Diclofenac—Leukopenia—Epirubicin—uterine cancer	4.01e-05	0.000284	CcSEcCtD
Diclofenac—Back pain—Doxorubicin—uterine cancer	4.01e-05	0.000284	CcSEcCtD
Diclofenac—Muscle spasms—Doxorubicin—uterine cancer	3.99e-05	0.000282	CcSEcCtD
Diclofenac—Palpitations—Epirubicin—uterine cancer	3.96e-05	0.00028	CcSEcCtD
Diclofenac—Loss of consciousness—Epirubicin—uterine cancer	3.94e-05	0.000278	CcSEcCtD
Diclofenac—Cough—Epirubicin—uterine cancer	3.91e-05	0.000276	CcSEcCtD
Diclofenac—Vision blurred—Doxorubicin—uterine cancer	3.91e-05	0.000276	CcSEcCtD
Diclofenac—Convulsion—Epirubicin—uterine cancer	3.88e-05	0.000274	CcSEcCtD
Diclofenac—Nausea—Etoposide—uterine cancer	3.87e-05	0.000274	CcSEcCtD
Diclofenac—Hypertension—Epirubicin—uterine cancer	3.87e-05	0.000274	CcSEcCtD
Diclofenac—Ill-defined disorder—Doxorubicin—uterine cancer	3.85e-05	0.000272	CcSEcCtD
Diclofenac—Anaemia—Doxorubicin—uterine cancer	3.83e-05	0.000271	CcSEcCtD
Diclofenac—Arthralgia—Epirubicin—uterine cancer	3.81e-05	0.00027	CcSEcCtD
Diclofenac—Chest pain—Epirubicin—uterine cancer	3.81e-05	0.00027	CcSEcCtD
Diclofenac—Myalgia—Epirubicin—uterine cancer	3.81e-05	0.00027	CcSEcCtD
Diclofenac—Agitation—Doxorubicin—uterine cancer	3.81e-05	0.000269	CcSEcCtD
Diclofenac—Anxiety—Epirubicin—uterine cancer	3.8e-05	0.000269	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	3.79e-05	0.000268	CcSEcCtD
Diclofenac—Discomfort—Epirubicin—uterine cancer	3.77e-05	0.000266	CcSEcCtD
Diclofenac—Malaise—Doxorubicin—uterine cancer	3.74e-05	0.000264	CcSEcCtD
Diclofenac—Dry mouth—Epirubicin—uterine cancer	3.73e-05	0.000264	CcSEcCtD
Diclofenac—Vertigo—Doxorubicin—uterine cancer	3.72e-05	0.000263	CcSEcCtD
Diclofenac—Syncope—Doxorubicin—uterine cancer	3.72e-05	0.000263	CcSEcCtD
Diclofenac—Leukopenia—Doxorubicin—uterine cancer	3.71e-05	0.000262	CcSEcCtD
Diclofenac—Confusional state—Epirubicin—uterine cancer	3.69e-05	0.000261	CcSEcCtD
Diclofenac—Palpitations—Doxorubicin—uterine cancer	3.66e-05	0.000259	CcSEcCtD
Diclofenac—Anaphylactic shock—Epirubicin—uterine cancer	3.66e-05	0.000259	CcSEcCtD
Diclofenac—Oedema—Epirubicin—uterine cancer	3.66e-05	0.000259	CcSEcCtD
Diclofenac—Loss of consciousness—Doxorubicin—uterine cancer	3.64e-05	0.000258	CcSEcCtD
Diclofenac—Infection—Epirubicin—uterine cancer	3.63e-05	0.000257	CcSEcCtD
Diclofenac—Cough—Doxorubicin—uterine cancer	3.62e-05	0.000256	CcSEcCtD
Diclofenac—Shock—Epirubicin—uterine cancer	3.6e-05	0.000254	CcSEcCtD
Diclofenac—Convulsion—Doxorubicin—uterine cancer	3.59e-05	0.000254	CcSEcCtD
Diclofenac—Nervous system disorder—Epirubicin—uterine cancer	3.59e-05	0.000254	CcSEcCtD
Diclofenac—Thrombocytopenia—Epirubicin—uterine cancer	3.58e-05	0.000253	CcSEcCtD
Diclofenac—Hypertension—Doxorubicin—uterine cancer	3.58e-05	0.000253	CcSEcCtD
Diclofenac—Tachycardia—Epirubicin—uterine cancer	3.57e-05	0.000252	CcSEcCtD
Diclofenac—Skin disorder—Epirubicin—uterine cancer	3.55e-05	0.000251	CcSEcCtD
Diclofenac—Hyperhidrosis—Epirubicin—uterine cancer	3.54e-05	0.00025	CcSEcCtD
Diclofenac—Chest pain—Doxorubicin—uterine cancer	3.53e-05	0.00025	CcSEcCtD
Diclofenac—Myalgia—Doxorubicin—uterine cancer	3.53e-05	0.00025	CcSEcCtD
Diclofenac—Arthralgia—Doxorubicin—uterine cancer	3.53e-05	0.00025	CcSEcCtD
Diclofenac—Anxiety—Doxorubicin—uterine cancer	3.52e-05	0.000249	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	3.51e-05	0.000248	CcSEcCtD
Diclofenac—Discomfort—Doxorubicin—uterine cancer	3.49e-05	0.000247	CcSEcCtD
Diclofenac—Anorexia—Epirubicin—uterine cancer	3.49e-05	0.000246	CcSEcCtD
Diclofenac—Dry mouth—Doxorubicin—uterine cancer	3.45e-05	0.000244	CcSEcCtD
Diclofenac—Hypotension—Epirubicin—uterine cancer	3.42e-05	0.000242	CcSEcCtD
Diclofenac—Confusional state—Doxorubicin—uterine cancer	3.41e-05	0.000241	CcSEcCtD
Diclofenac—Anaphylactic shock—Doxorubicin—uterine cancer	3.38e-05	0.000239	CcSEcCtD
Diclofenac—Oedema—Doxorubicin—uterine cancer	3.38e-05	0.000239	CcSEcCtD
Diclofenac—Infection—Doxorubicin—uterine cancer	3.36e-05	0.000238	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Epirubicin—uterine cancer	3.33e-05	0.000236	CcSEcCtD
Diclofenac—Shock—Doxorubicin—uterine cancer	3.33e-05	0.000235	CcSEcCtD
Diclofenac—Nervous system disorder—Doxorubicin—uterine cancer	3.32e-05	0.000235	CcSEcCtD
Diclofenac—Thrombocytopenia—Doxorubicin—uterine cancer	3.31e-05	0.000234	CcSEcCtD
Diclofenac—Insomnia—Epirubicin—uterine cancer	3.31e-05	0.000234	CcSEcCtD
Diclofenac—Tachycardia—Doxorubicin—uterine cancer	3.3e-05	0.000233	CcSEcCtD
Diclofenac—Skin disorder—Doxorubicin—uterine cancer	3.29e-05	0.000232	CcSEcCtD
Diclofenac—Paraesthesia—Epirubicin—uterine cancer	3.28e-05	0.000232	CcSEcCtD
Diclofenac—Hyperhidrosis—Doxorubicin—uterine cancer	3.27e-05	0.000231	CcSEcCtD
Diclofenac—Dyspnoea—Epirubicin—uterine cancer	3.26e-05	0.000231	CcSEcCtD
Diclofenac—Somnolence—Epirubicin—uterine cancer	3.25e-05	0.00023	CcSEcCtD
Diclofenac—Anorexia—Doxorubicin—uterine cancer	3.23e-05	0.000228	CcSEcCtD
Diclofenac—Dyspepsia—Epirubicin—uterine cancer	3.22e-05	0.000228	CcSEcCtD
Diclofenac—Decreased appetite—Epirubicin—uterine cancer	3.18e-05	0.000225	CcSEcCtD
Diclofenac—Hypotension—Doxorubicin—uterine cancer	3.16e-05	0.000224	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Epirubicin—uterine cancer	3.16e-05	0.000223	CcSEcCtD
Diclofenac—Fatigue—Epirubicin—uterine cancer	3.15e-05	0.000223	CcSEcCtD
Diclofenac—Constipation—Epirubicin—uterine cancer	3.13e-05	0.000221	CcSEcCtD
Diclofenac—Pain—Epirubicin—uterine cancer	3.13e-05	0.000221	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Doxorubicin—uterine cancer	3.08e-05	0.000218	CcSEcCtD
Diclofenac—Insomnia—Doxorubicin—uterine cancer	3.06e-05	0.000216	CcSEcCtD
Diclofenac—Paraesthesia—Doxorubicin—uterine cancer	3.04e-05	0.000215	CcSEcCtD
Diclofenac—Dyspnoea—Doxorubicin—uterine cancer	3.02e-05	0.000213	CcSEcCtD
Diclofenac—Feeling abnormal—Epirubicin—uterine cancer	3.01e-05	0.000213	CcSEcCtD
Diclofenac—Somnolence—Doxorubicin—uterine cancer	3.01e-05	0.000213	CcSEcCtD
Diclofenac—Gastrointestinal pain—Epirubicin—uterine cancer	2.99e-05	0.000211	CcSEcCtD
Diclofenac—Dyspepsia—Doxorubicin—uterine cancer	2.98e-05	0.000211	CcSEcCtD
Diclofenac—Decreased appetite—Doxorubicin—uterine cancer	2.94e-05	0.000208	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Doxorubicin—uterine cancer	2.92e-05	0.000207	CcSEcCtD
Diclofenac—Fatigue—Doxorubicin—uterine cancer	2.92e-05	0.000206	CcSEcCtD
Diclofenac—Urticaria—Epirubicin—uterine cancer	2.9e-05	0.000205	CcSEcCtD
Diclofenac—Pain—Doxorubicin—uterine cancer	2.89e-05	0.000205	CcSEcCtD
Diclofenac—Constipation—Doxorubicin—uterine cancer	2.89e-05	0.000205	CcSEcCtD
Diclofenac—Abdominal pain—Epirubicin—uterine cancer	2.89e-05	0.000204	CcSEcCtD
Diclofenac—Body temperature increased—Epirubicin—uterine cancer	2.89e-05	0.000204	CcSEcCtD
Diclofenac—Feeling abnormal—Doxorubicin—uterine cancer	2.79e-05	0.000197	CcSEcCtD
Diclofenac—Gastrointestinal pain—Doxorubicin—uterine cancer	2.77e-05	0.000196	CcSEcCtD
Diclofenac—Hypersensitivity—Epirubicin—uterine cancer	2.69e-05	0.00019	CcSEcCtD
Diclofenac—Urticaria—Doxorubicin—uterine cancer	2.69e-05	0.00019	CcSEcCtD
Diclofenac—Body temperature increased—Doxorubicin—uterine cancer	2.67e-05	0.000189	CcSEcCtD
Diclofenac—Abdominal pain—Doxorubicin—uterine cancer	2.67e-05	0.000189	CcSEcCtD
Diclofenac—Asthenia—Epirubicin—uterine cancer	2.62e-05	0.000186	CcSEcCtD
Diclofenac—Pruritus—Epirubicin—uterine cancer	2.59e-05	0.000183	CcSEcCtD
Diclofenac—Diarrhoea—Epirubicin—uterine cancer	2.5e-05	0.000177	CcSEcCtD
Diclofenac—Hypersensitivity—Doxorubicin—uterine cancer	2.49e-05	0.000176	CcSEcCtD
Diclofenac—Asthenia—Doxorubicin—uterine cancer	2.43e-05	0.000172	CcSEcCtD
Diclofenac—Dizziness—Epirubicin—uterine cancer	2.42e-05	0.000171	CcSEcCtD
Diclofenac—Pruritus—Doxorubicin—uterine cancer	2.39e-05	0.000169	CcSEcCtD
Diclofenac—Vomiting—Epirubicin—uterine cancer	2.32e-05	0.000164	CcSEcCtD
Diclofenac—Diarrhoea—Doxorubicin—uterine cancer	2.31e-05	0.000164	CcSEcCtD
Diclofenac—Rash—Epirubicin—uterine cancer	2.31e-05	0.000163	CcSEcCtD
Diclofenac—Dermatitis—Epirubicin—uterine cancer	2.3e-05	0.000163	CcSEcCtD
Diclofenac—Headache—Epirubicin—uterine cancer	2.29e-05	0.000162	CcSEcCtD
Diclofenac—Dizziness—Doxorubicin—uterine cancer	2.24e-05	0.000158	CcSEcCtD
Diclofenac—Nausea—Epirubicin—uterine cancer	2.17e-05	0.000154	CcSEcCtD
Diclofenac—Vomiting—Doxorubicin—uterine cancer	2.15e-05	0.000152	CcSEcCtD
Diclofenac—Rash—Doxorubicin—uterine cancer	2.13e-05	0.000151	CcSEcCtD
Diclofenac—Dermatitis—Doxorubicin—uterine cancer	2.13e-05	0.000151	CcSEcCtD
Diclofenac—Headache—Doxorubicin—uterine cancer	2.12e-05	0.00015	CcSEcCtD
Diclofenac—Nausea—Doxorubicin—uterine cancer	2.01e-05	0.000142	CcSEcCtD
Diclofenac—CXCR1—Signaling Pathways—PIK3CA—uterine cancer	7.76e-06	0.000137	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—AKR1C3—uterine cancer	7.67e-06	0.000135	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	7.61e-06	0.000134	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CTNNB1—uterine cancer	7.59e-06	0.000134	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—PTEN—uterine cancer	7.56e-06	0.000133	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AKR1C1—uterine cancer	7.53e-06	0.000133	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—RRM2—uterine cancer	7.52e-06	0.000133	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—AKR1C3—uterine cancer	7.52e-06	0.000133	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TP53—uterine cancer	7.51e-06	0.000132	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CYP11A1—uterine cancer	7.5e-06	0.000132	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—NRAS—uterine cancer	7.5e-06	0.000132	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—HRAS—uterine cancer	7.49e-06	0.000132	CbGpPWpGaD
Diclofenac—ALB—Metabolism—RRM2—uterine cancer	7.48e-06	0.000132	CbGpPWpGaD
Diclofenac—TTR—Disease—PIK3CA—uterine cancer	7.46e-06	0.000132	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—PTEN—uterine cancer	7.4e-06	0.000131	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.36e-06	0.00013	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AKR1C1—uterine cancer	7.35e-06	0.00013	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—POLD1—uterine cancer	7.34e-06	0.00013	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—DCN—uterine cancer	7.3e-06	0.000129	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—PIK3CA—uterine cancer	7.26e-06	0.000128	CbGpPWpGaD
Diclofenac—ALB—Metabolism—DCN—uterine cancer	7.26e-06	0.000128	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—MTHFR—uterine cancer	7.22e-06	0.000127	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—EP300—uterine cancer	7.21e-06	0.000127	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—HRAS—uterine cancer	7.18e-06	0.000127	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	7.1e-06	0.000125	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—AKR1C3—uterine cancer	7.09e-06	0.000125	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—EP300—uterine cancer	7.06e-06	0.000124	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.02e-06	0.000124	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	6.99e-06	0.000123	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CCL2—uterine cancer	6.98e-06	0.000123	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—MTHFR—uterine cancer	6.97e-06	0.000123	CbGpPWpGaD
Diclofenac—TTR—Disease—HRAS—uterine cancer	6.9e-06	0.000122	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CYP11A1—uterine cancer	6.88e-06	0.000121	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AKR1C1—uterine cancer	6.87e-06	0.000121	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CYP11A1—uterine cancer	6.84e-06	0.000121	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	6.77e-06	0.000119	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—RRM2—uterine cancer	6.71e-06	0.000118	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—VEGFA—uterine cancer	6.69e-06	0.000118	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CDKN2B—uterine cancer	6.66e-06	0.000117	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—AKT1—uterine cancer	6.61e-06	0.000117	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—NRAS—uterine cancer	6.6e-06	0.000116	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—RRM2—uterine cancer	6.55e-06	0.000116	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—PIK3CA—uterine cancer	6.53e-06	0.000115	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—DCN—uterine cancer	6.52e-06	0.000115	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—AKR1C3—uterine cancer	6.5e-06	0.000115	CbGpPWpGaD
Diclofenac—ALB—Metabolism—AKR1C3—uterine cancer	6.46e-06	0.000114	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—KRAS—uterine cancer	6.45e-06	0.000114	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—DCN—uterine cancer	6.36e-06	0.000112	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—AKT1—uterine cancer	6.34e-06	0.000112	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—POLD1—uterine cancer	6.28e-06	0.000111	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CYP19A1—uterine cancer	6.22e-06	0.00011	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—STK11—uterine cancer	6.22e-06	0.00011	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AKR1B1—uterine cancer	6.17e-06	0.000109	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—STAR—uterine cancer	6.17e-06	0.000109	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CYP11A1—uterine cancer	6.14e-06	0.000108	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.14e-06	0.000108	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—RRM2—uterine cancer	6.12e-06	0.000108	CbGpPWpGaD
Diclofenac—TTR—Disease—AKT1—uterine cancer	6.09e-06	0.000107	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SMAD3—uterine cancer	6.08e-06	0.000107	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CYP11A1—uterine cancer	5.99e-06	0.000106	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—STK11—uterine cancer	5.98e-06	0.000105	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CYP19A1—uterine cancer	5.98e-06	0.000105	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—DCN—uterine cancer	5.94e-06	0.000105	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—AKT1—uterine cancer	5.93e-06	0.000105	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—PIK3CA—uterine cancer	5.93e-06	0.000105	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—MTHFR—uterine cancer	5.89e-06	0.000104	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AKR1C1—uterine cancer	5.87e-06	0.000104	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—STK11—uterine cancer	5.86e-06	0.000103	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CYP19A1—uterine cancer	5.86e-06	0.000103	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.84e-06	0.000103	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—ERBB2—uterine cancer	5.82e-06	0.000103	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	5.8e-06	0.000102	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AKR1C3—uterine cancer	5.8e-06	0.000102	CbGpPWpGaD
Diclofenac—PTGS2—Disease—FGFR2—uterine cancer	5.8e-06	0.000102	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	5.71e-06	0.000101	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—KRAS—uterine cancer	5.68e-06	0.0001	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AKR1C3—uterine cancer	5.66e-06	9.98e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CYP11A1—uterine cancer	5.6e-06	9.88e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MTHFR—uterine cancer	5.58e-06	9.84e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.57e-06	9.82e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—STK11—uterine cancer	5.52e-06	9.74e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CYP19A1—uterine cancer	5.52e-06	9.74e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—HRAS—uterine cancer	5.49e-06	9.67e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—ERBB2—uterine cancer	5.43e-06	9.57e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CDKN1B—uterine cancer	5.39e-06	9.51e-05	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—AKT1—uterine cancer	5.33e-06	9.41e-05	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—PIK3CA—uterine cancer	5.33e-06	9.4e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AKR1C3—uterine cancer	5.29e-06	9.33e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—RRM2—uterine cancer	5.23e-06	9.23e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—PIK3CA—uterine cancer	5.22e-06	9.21e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.19e-06	9.15e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.18e-06	9.14e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CTNNB1—uterine cancer	5.09e-06	8.98e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PTEN—uterine cancer	5.08e-06	8.97e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—DCN—uterine cancer	5.08e-06	8.96e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—STK11—uterine cancer	5.06e-06	8.93e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CYP19A1—uterine cancer	5.06e-06	8.93e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TP53—uterine cancer	5.05e-06	8.91e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—STK11—uterine cancer	5.03e-06	8.88e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CYP19A1—uterine cancer	5.03e-06	8.88e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CDKN1B—uterine cancer	5.03e-06	8.86e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PTEN—uterine cancer	4.96e-06	8.76e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—EP300—uterine cancer	4.95e-06	8.73e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PTEN—uterine cancer	4.95e-06	8.72e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.94e-06	8.72e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—EP300—uterine cancer	4.85e-06	8.55e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—POLD1—uterine cancer	4.84e-06	8.54e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—AKT1—uterine cancer	4.84e-06	8.54e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—HRAS—uterine cancer	4.83e-06	8.52e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP11A1—uterine cancer	4.79e-06	8.44e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.75e-06	8.38e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CTNNB1—uterine cancer	4.75e-06	8.37e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—EP300—uterine cancer	4.73e-06	8.35e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.72e-06	8.33e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—EP300—uterine cancer	4.72e-06	8.32e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—VEGFA—uterine cancer	4.69e-06	8.27e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—MTHFR—uterine cancer	4.67e-06	8.24e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—NRAS—uterine cancer	4.63e-06	8.17e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PTEN—uterine cancer	4.63e-06	8.16e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.53e-06	7.99e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AKR1C1—uterine cancer	4.53e-06	7.99e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AKR1C3—uterine cancer	4.52e-06	7.97e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—STK11—uterine cancer	4.52e-06	7.97e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CYP19A1—uterine cancer	4.52e-06	7.97e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.51e-06	7.95e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—MTHFR—uterine cancer	4.49e-06	7.92e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—VEGFA—uterine cancer	4.48e-06	7.91e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—NRAS—uterine cancer	4.43e-06	7.81e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—EP300—uterine cancer	4.41e-06	7.78e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—STK11—uterine cancer	4.41e-06	7.78e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CYP19A1—uterine cancer	4.41e-06	7.78e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—MTHFR—uterine cancer	4.4e-06	7.76e-05	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—AKT1—uterine cancer	4.35e-06	7.68e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—AKT1—uterine cancer	4.27e-06	7.52e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.24e-06	7.48e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—MTHFR—uterine cancer	4.15e-06	7.32e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—NRAS—uterine cancer	4.13e-06	7.28e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—STK11—uterine cancer	4.12e-06	7.27e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CYP19A1—uterine cancer	4.12e-06	7.27e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.12e-06	7.27e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.04e-06	7.13e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—RRM2—uterine cancer	4.04e-06	7.12e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PTEN—uterine cancer	4.02e-06	7.09e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—KRAS—uterine cancer	3.98e-06	7.03e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—DCN—uterine cancer	3.92e-06	6.91e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PTEN—uterine cancer	3.88e-06	6.83e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.87e-06	6.82e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—EP300—uterine cancer	3.83e-06	6.76e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—KRAS—uterine cancer	3.81e-06	6.72e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—MTHFR—uterine cancer	3.8e-06	6.71e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—MTHFR—uterine cancer	3.78e-06	6.67e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—EP300—uterine cancer	3.7e-06	6.52e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP11A1—uterine cancer	3.69e-06	6.51e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.69e-06	6.5e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—PIK3CA—uterine cancer	3.66e-06	6.46e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.66e-06	6.45e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—ERBB2—uterine cancer	3.64e-06	6.42e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PIK3CA—uterine cancer	3.59e-06	6.33e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—KRAS—uterine cancer	3.55e-06	6.27e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—uterine cancer	3.54e-06	6.25e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—STK11—uterine cancer	3.52e-06	6.21e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP19A1—uterine cancer	3.52e-06	6.21e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PIK3CA—uterine cancer	3.5e-06	6.18e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PIK3CA—uterine cancer	3.49e-06	6.15e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AKR1C3—uterine cancer	3.49e-06	6.15e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—MTHFR—uterine cancer	3.4e-06	5.99e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—uterine cancer	3.39e-06	5.98e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—HRAS—uterine cancer	3.39e-06	5.97e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CDKN1B—uterine cancer	3.37e-06	5.95e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.35e-06	5.91e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.33e-06	5.88e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—MTHFR—uterine cancer	3.31e-06	5.84e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.3e-06	5.83e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTEN—uterine cancer	3.28e-06	5.78e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PIK3CA—uterine cancer	3.26e-06	5.76e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HRAS—uterine cancer	3.24e-06	5.71e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CTNNB1—uterine cancer	3.19e-06	5.62e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.15e-06	5.56e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—EP300—uterine cancer	3.12e-06	5.51e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PTEN—uterine cancer	3.11e-06	5.48e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—MTHFR—uterine cancer	3.1e-06	5.46e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—HRAS—uterine cancer	3.02e-06	5.33e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.99e-06	5.28e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—AKT1—uterine cancer	2.99e-06	5.27e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EP300—uterine cancer	2.96e-06	5.22e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—AKT1—uterine cancer	2.93e-06	5.17e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AKT1—uterine cancer	2.86e-06	5.05e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—AKT1—uterine cancer	2.85e-06	5.03e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PIK3CA—uterine cancer	2.84e-06	5e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NRAS—uterine cancer	2.77e-06	4.89e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PIK3CA—uterine cancer	2.73e-06	4.82e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.73e-06	4.81e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP19A1—uterine cancer	2.72e-06	4.79e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—STK11—uterine cancer	2.72e-06	4.79e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—AKT1—uterine cancer	2.67e-06	4.7e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—MTHFR—uterine cancer	2.65e-06	4.67e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PTEN—uterine cancer	2.6e-06	4.59e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTEN—uterine cancer	2.5e-06	4.41e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—EP300—uterine cancer	2.48e-06	4.37e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTEN—uterine cancer	2.45e-06	4.32e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—KRAS—uterine cancer	2.38e-06	4.21e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—EP300—uterine cancer	2.38e-06	4.2e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—EP300—uterine cancer	2.33e-06	4.12e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.33e-06	4.11e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—AKT1—uterine cancer	2.32e-06	4.08e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CA—uterine cancer	2.31e-06	4.08e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTEN—uterine cancer	2.31e-06	4.07e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—AKT1—uterine cancer	2.23e-06	3.94e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—EP300—uterine cancer	2.2e-06	3.88e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CA—uterine cancer	2.19e-06	3.86e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTEN—uterine cancer	2.12e-06	3.73e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTEN—uterine cancer	2.1e-06	3.71e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—MTHFR—uterine cancer	2.04e-06	3.6e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HRAS—uterine cancer	2.03e-06	3.57e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—EP300—uterine cancer	2.02e-06	3.56e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—EP300—uterine cancer	2.01e-06	3.54e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTEN—uterine cancer	1.89e-06	3.33e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—AKT1—uterine cancer	1.89e-06	3.33e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTEN—uterine cancer	1.84e-06	3.25e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CA—uterine cancer	1.83e-06	3.24e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—EP300—uterine cancer	1.8e-06	3.18e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—AKT1—uterine cancer	1.79e-06	3.16e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CA—uterine cancer	1.76e-06	3.11e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—EP300—uterine cancer	1.76e-06	3.1e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CA—uterine cancer	1.73e-06	3.05e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTEN—uterine cancer	1.72e-06	3.04e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—EP300—uterine cancer	1.64e-06	2.9e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CA—uterine cancer	1.63e-06	2.87e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—AKT1—uterine cancer	1.5e-06	2.64e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CA—uterine cancer	1.49e-06	2.63e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CA—uterine cancer	1.48e-06	2.62e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTEN—uterine cancer	1.47e-06	2.6e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—AKT1—uterine cancer	1.44e-06	2.54e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—AKT1—uterine cancer	1.41e-06	2.49e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—EP300—uterine cancer	1.4e-06	2.48e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.33e-06	2.35e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—AKT1—uterine cancer	1.33e-06	2.35e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CA—uterine cancer	1.3e-06	2.29e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—AKT1—uterine cancer	1.22e-06	2.15e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.22e-06	2.14e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—AKT1—uterine cancer	1.21e-06	2.14e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTEN—uterine cancer	1.14e-06	2e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AKT1—uterine cancer	1.09e-06	1.92e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—EP300—uterine cancer	1.08e-06	1.91e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AKT1—uterine cancer	1.06e-06	1.87e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.04e-06	1.83e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AKT1—uterine cancer	9.93e-07	1.75e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AKT1—uterine cancer	8.48e-07	1.5e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CA—uterine cancer	8.01e-07	1.41e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AKT1—uterine cancer	6.55e-07	1.15e-05	CbGpPWpGaD
